Affiance Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $308K | Hold |
2,774
| – | – | 0.06% | 84 |
|
|
2025
Q1 | $311K | Sell |
2,774
-757
| -21% | -$84.8K | 0.07% | 82 |
|
|
2024
Q4 | $326K | Hold |
3,531
| – | – | 0.08% | 82 |
|
|
2024
Q3 | $296K | Hold |
3,531
| – | – | 0.07% | 85 |
|
|
2024
Q2 | $242K | Buy |
+3,531
| New | +$242K | 0.06% | 87 |
|
|
2023
Q1 | – | Sell |
-1,413
| Closed | -$121K | – | 215 |
|
|
2022
Q4 | $121K | Buy |
+1,413
| New | +$121K | 0.05% | 122 |
|
|
2017
Q4 | – | Sell |
-3,171
| Closed | -$257K | – | 81 |
|
|
2017
Q3 | $257K | Sell |
3,171
-100
| -3% | -$8.11K | 0.21% | 67 |
|
|
2017
Q2 | $232K | Buy |
3,271
+49
| +2% | +$3.48K | 0.18% | 69 |
|
|
2017
Q1 | $219K | Sell |
3,222
-4,531
| -58% | -$308K | 0.17% | 72 |
|
|
2016
Q4 | $555K | Sell |
7,753
-100
| -1% | -$7.16K | 0.44% | 39 |
|
|
2016
Q3 | $621K | Buy |
7,853
+200
| +3% | +$15.8K | 0.5% | 36 |
|
|
2016
Q2 | $638K | Buy |
7,653
+100
| +1% | +$8.34K | 0.54% | 36 |
|
|
2016
Q1 | $694K | Buy |
+7,553
| New | +$694K | 0.66% | 32 |
|